The diagnostic accuracy estimates of the unstimulated CSF IFN-γ in the current study are similar to those reported for CSF ADA by Pormohammad et al. Overall, this suggests that unstimulated CSF IFN-γ may be as useful as currently common diagnostic biomarkers, such as ADA, for TBM. The gene discussed is ADA; the disease is meningeal tuberculosis.